ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.691,32
0,05%
S&P 500
5.281,74
-0,48%
Dow Jones
39.151,66
-1,31%
Euro vs US Dollar
1,08152
-0,09%
Bitcoin
67.671,48
-2,07%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. IGM Biosciences Inc (IGMS)

  7. IGM Biosciences Inc (IGMS) News

IGMS

IGM Biosciences (IGMS)

IGM Biosciences Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:IGMS
DatumZeitQuelleÜberschriftSymbolFirma
08/05/202422h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IGMSIGM Biosciences Inc
08/05/202422h10GlobeNewswire Inc.IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:IGMSIGM Biosciences Inc
08/05/202422h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IGMSIGM Biosciences Inc
07/05/202413h00GlobeNewswire Inc.IGM Biosciences to Present at the 2024 RBCCM Global Healthcare ConferenceNASDAQ:IGMSIGM Biosciences Inc
17/04/202414h30GlobeNewswire Inc.IGM Biosciences Announces Refocusing of Sanofi CollaborationNASDAQ:IGMSIGM Biosciences Inc
10/04/202413h00GlobeNewswire Inc.IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology ForumNASDAQ:IGMSIGM Biosciences Inc
07/03/202422h27Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:IGMSIGM Biosciences Inc
07/03/202422h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IGMSIGM Biosciences Inc
07/03/202422h10GlobeNewswire Inc.IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:IGMSIGM Biosciences Inc
06/03/202401h34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
01/02/202413h00GlobeNewswire Inc.IGM Biosciences to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceNASDAQ:IGMSIGM Biosciences Inc
08/01/202415h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IGMSIGM Biosciences Inc
04/01/202402h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
04/01/202400h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
04/01/202400h16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
03/01/202413h00GlobeNewswire Inc.IGM Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:IGMSIGM Biosciences Inc
16/12/202301h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
16/12/202301h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
16/12/202301h18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
13/12/202323h36Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IGMSIGM Biosciences Inc
13/12/202323h33Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IGMSIGM Biosciences Inc
13/12/202323h30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IGMSIGM Biosciences Inc
13/12/202323h27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IGMSIGM Biosciences Inc
08/12/202322h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IGMSIGM Biosciences Inc
05/12/202322h01GlobeNewswire Inc.IGM Biosciences Announces Strategic Pipeline Prioritization and Cash Runway ExtensionNASDAQ:IGMSIGM Biosciences Inc
02/12/202301h03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
02/12/202301h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
02/12/202301h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
01/12/202311h32PR Newswire (US)Bulletin from Extraordinary General Meeting in Medivir AB (publ)NASDAQ:IGMSIGM Biosciences Inc
30/11/202302h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IGMSIGM Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:IGMS

Kürzlich von Ihnen besucht

NYSE
TCAF
T. Rowe Price Ex
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten